Chuen-Lin Din

Title: Innovations by Chuen-Lin Din in Neurodegenerative Disorder Treatments

Introduction

Chuen-Lin Din is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative disorders. With a total of 2 patents to his name, Din's work focuses on innovative oral dosage formulations that enhance drug delivery and efficacy.

Latest Patents

Din's latest patents include an oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders. This formulation features an acetylcholinesterase inhibitor (AChEI) that releases more than 80% of the drug within 60 minutes, alongside memantine, which has a sustained-release profile allowing for over 80% dissolution within 12 hours. Another patent details a method for treating patients with central nervous system disorders using this oral dosage formulation, ensuring optimal blood levels of both the AChEI and memantine over specified time frames.

Career Highlights

Chuen-Lin Din is associated with Center Laboratories, Inc., where he continues to develop innovative solutions for complex medical challenges. His work is characterized by a commitment to improving patient outcomes through advanced pharmaceutical formulations.

Collaborations

Din collaborates with esteemed colleagues such as Chien-Fen Chen and Huai-Cheng Lee, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Chuen-Lin Din's contributions to the field of neurodegenerative disorder treatments exemplify the impact of innovative thinking in pharmaceuticals. His patents reflect a dedication to enhancing drug delivery systems, ultimately benefiting patients in need.